Paraplatin and Zoledronic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paraplatin (carboplatin) and Zoledronic (zoledronic acid). Common drug interactions include constipation among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Paraplatin and Zoledronic. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Paraplatin?

Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.

On Jul, 17, 2026

25 people who take Paraplatin and Zoledronic together, and have interactions are studied.

Paraplatin and Zoledronic drug interactions.

What are the common drug interactions of Paraplatin and Zoledronic, by gender? *:

female:

Constipation
Dizziness
Dry eye (lack of adequate tears)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypokalaemia (low potassium)
Muscle spasms (muscle contraction)
Upper respiratory tract infection
Hypersensitivity
Arthralgia (joint pain)
Diarrhoea

male:

Decreased appetite
Nausea (feeling of having an urge to vomit)
Malignant neoplasm progression (cancer tumour came back)
Metastases to bone (cancer spreads to bone)
Neoplasm malignant (cancer tumour)
Small cell lung cancer metastatic (lung cancer spreads to other body parts)
Arthralgia (joint pain)
Back pain
Blood creatine phosphokinase increased
Bone marrow failure

What are the common drug interactions of Paraplatin and Zoledronic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Arthralgia (joint pain)
Constipation
Diarrhoea
Dizziness
Dry eye (lack of adequate tears)
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Headache (pain in head)
Hypersensitivity
Hypokalaemia (low potassium)

40-49:

n/a

50-59:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Pyrexia (fever)
Alopecia (absence of hair from areas of the body)
Febrile neutropenia (fever with reduced white blood cells)
Psychological trauma

60+:

Decreased appetite
Nausea (feeling of having an urge to vomit)
Malignant neoplasm progression (cancer tumour came back)
Metastases to bone (cancer spreads to bone)
Neoplasm malignant (cancer tumour)
Small cell lung cancer metastatic (lung cancer spreads to other body parts)
Alopecia (absence of hair from areas of the body)
Back pain
Blood creatine phosphokinase increased
Bone marrow failure

What are the existing conditions these people have? *

Breast Cancer: 14 people, 56.00%
Joint Pain: 12 people, 48.00%
Headache (pain in head): 12 people, 48.00%
Ejection Fraction Decreased (systolic heart failure): 4 people, 16.00%
Constipation: 3 people, 12.00%
Breast Cancer Female: 3 people, 12.00%
Dry Eyes (lack of adequate tears): 2 people, 8.00%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Paraplatin and Zoledronic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously